基础医学与临床 ›› 2019, Vol. 39 ›› Issue (4): 501-508.

• 研究论文 • 上一篇    下一篇

腺相关病毒介导的体内睾丸组织基因特异性敲除系统的建立

邹定峰1,罗艳云2,李凯2,卢艳1,李永玲3,缪时英4,王琳芳4,宋伟2   

  1. 1. 中国医学科学院 基础医学研究所 北京协和医学院 基础学院
    2. 中国医学科学院基础医学研究所
    3. 河北石家庄无极县医院
    4. 中国医学科学院 基础医学研究所
  • 收稿日期:2018-12-24 修回日期:2019-01-15 出版日期:2019-04-05 发布日期:2019-03-26
  • 通讯作者: 宋伟 E-mail:songwei@ibms.pumc.edu.cn
  • 基金资助:
    国家重点基础研究计划;中国医学科学院医学与健康科技创新工程

Establishment of adeno-associated virus-mediated gene-specific knockout system in testis

  • Received:2018-12-24 Revised:2019-01-15 Online:2019-04-05 Published:2019-03-26
  • Supported by:
    National Key Basic Research Program of China;CAMS Innovation Fund for Medical Sciences

摘要: 目的 建立一套可用于体内睾丸组织特异性敲除基因的系统。方法 利用同源重组技术将CRISPR/Cas9 系统中sgRNA功能元件插入到AAV表达载体,将人源Wee1 2# sgRNA构建入改造的AAV-sgRNA(新版)载体中进行病毒包装,并感染稳定表达Cas9 的Hela-spCas9细胞验证该载体的基因敲除效率。筛选睾丸组织特异表达基因Sycp3的sgRNA靶点,构建入AAV-sgRNA(新版)载体中,进行病毒包装,利用显微注射技术将病毒注射入小鼠睾丸组织曲细精管内,通过T7E1分析体内细胞的基因敲除效果。结果 构建成功的AAV-sgRNA载体能够进行病毒包装并在体外细胞水平上对人源Wee1进行基因编辑,与慢病毒介导的CRISPR/Cas9系统中的载体编辑效率相比无明显差异。同时,该系统能在体内水平对Sycp3进行基因编辑。结论 成功建立一套可用于在体内睾丸组织中进行特异性敲除目标基因的系统,为生殖体内功能研究提供一个新的思路和方法。

关键词: CRISPR Cas9,AAV,病毒包装,T7E1,显微注射

Abstract: Objective To establish a system for the specific knockout genes of testis tissue in vivo. Methods The sgRNA functional elements in the CRISPR/Cas9 system were inserted into the AAV expression vector by homologous recombination technology, and the Wee1 2# sgRNA was constructed into the modified AAV-sgRNA (new version) vector for virus packaging. The efficiency of gene knockout of this vector was verified by infection with Hela-spCas9 cells stably expressing Cas9. The sgRNA target of the testis tissue-specific gene Sycp3 was screened and constructed into AAV-sgRNA (new version) vector for viral packaging. The virus was injected into the seminiferous tubule of mouse testicular tissue by microinjection technique, and the in vivo cells were analyzed by T7E1. Gene knockout effect. Results The successful construction of the AAV-sgRNA vector was able to perform viral packaging and gene editing of the human Wee1 gene at the cellular level in vitro, which was not significantly different from the vector editing efficiency in the Lentivirus-mediated CRISPR/Cas9 system. At the same time, the system can genetically edit Sycp3 at the level of the body. Conclusions A system for specifically knocking out target genes in testis tissue in vivo has been successfully established, which provides a new idea and method for the study of reproductive function in vivo.

Key words: CRISPR Cas9, AAV, virus packaging, T7E1,Microinjection

中图分类号: